ArticleFrontiers in pharmacology2025

Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a

Huaxiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.